Cloudbreak Pharma Inc. (HKG:2592)
Hong Kong · Delayed Price · Currency is HKD 1.190
+0.025 (2.15%)
Sep 9, 2026, 6:08 PM HKT
Cloudbreak Pharma Market Cap
Cloudbreak Pharma has a market cap or net worth of 1.1 billion as of November 2, 2026. It is the 22,779th most valuable company in the world and the 1,075th biggest in Hong Kong. Its market cap has decreased by 74.03% in one year.
Market Cap
1.10B
Enterprise Value
799.26M
Revenue
2.11M
Global Rank
Country Rank
#1,075 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since July 3, 2025, Cloudbreak Pharma's market cap has decreased from 5.20B to 1.10B, a decrease of -78.84%. That is a compound annual growth rate of -73.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 1.10B | -74.77% |
| Dec 31, 2025 | 4.36B | -16.13% |
| Jul 3, 2025 | 5.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guangzhou Innogen Pharmaceutical Group | 1.55B |
| SinoMab BioScience | 1.48B |
| Beijing Biostar Pharmaceuticals | 1.32B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.25B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.20B |
| TYK Medicines | 1.19B |
| Zhaoke Ophthalmology | 1.10B |
| CANbridge Pharmaceuticals | 1.06B |